HOFLAND, Kenneth F. et al. Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study. Acta Oncologica, [S. l.], v. 53, n. 7, p. 939–944, 2014. DOI: 10.3109/0284186X.2013.879607. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/27113. Acesso em: 21 may. 2026.